Ocean Biomedical, Inc. (OCEA) stock
OCEAOTCPharmaceutical PreparationsFiscal year ends December 31
Financials through Q1 FY2025, quarter ended Mar 31, 2025Last filing: 10-Q on May 15, 2025
$0.00−0.00 (-16.67%)
Close on Oct 19, 2026Market cap $45.51KP/E –Yield –
Ocean Biomedical shares outstanding
Diluted shares outstanding: the weighted share count used for earnings per share, adjusted for stock splits.
Ocean Biomedical's shares outstanding was 91M at Mar 31, 2025. For fiscal 2024 it was 28M, up 4.6% from the year before.
Annual shares outstanding
| Period | Period end | Value | Change |
|---|---|---|---|
| FY2024 | Dec 31, 2024 | 28M | +4.6% |
| FY2023 | Dec 31, 2023 | 26M | +12.6% |
| FY2022 | Dec 31, 2022 | 23M | – |
Quarterly shares outstanding
Change is against the same quarter a year earlier.
| Period | Period end | Value | Change |
|---|---|---|---|
| Q1 FY2025 | Mar 31, 2025 | 91M | +232.9% |
| Q4 FY2024 | Dec 31, 2024 | 28M | +1.6% |
| Q3 FY2024 | Sep 30, 2024 | 27M | +3.3% |
| Q2 FY2024 | Jun 30, 2024 | 27M | +3.8% |
| Q1 FY2024 | Mar 31, 2024 | 27M | +10.2% |
| Q4 FY2023 | Dec 31, 2023 | 27M | +16.6% |
| Q3 FY2023 | Sep 30, 2023 | 27M | +13.9% |
| Q2 FY2023 | Jun 30, 2023 | 26M | +13.3% |
| Q1 FY2023 | Mar 31, 2023 | 25M | +6.3% |
| Q4 FY2022 | Dec 31, 2022 | 23M | +785.6% |
| Q3 FY2022 | Sep 30, 2022 | 23M | – |
| Q2 FY2022 | Jun 30, 2022 | 23M | – |
| Q1 FY2022 | Mar 31, 2022 | 23M | – |
| Q3 FY2021 | Sep 30, 2021 | 3M | – |
See a number that looks wrong?